Expression Patterns of microRNAs and Associated Target Genes in Ulcerated Primary Cutaneous Melanoma

Mallory J DiVincenzo1, Emily Schwarz2, Casey Ren2

  • 1The James Cancer Hospital and Solove Research Institute, The Ohio State University, Columbus, Ohio, USA; Department of Veterinary Biosciences, The Ohio State University, Columbus, Ohio, USA.

Insights

Ulcerated melanoma, a severe skin cancer, shows distinct microRNA (miR) expression patterns. Researchers identified specific miRs and messenger RNAs (mRNAs) linked to this aggressive tumor subtype, offering new molecular insights.

Area of Science:

  • Oncology
  • Molecular Biology
  • Genetics

Background:

  • Ulcerated cutaneous melanoma is associated with poor prognosis.
  • The molecular mechanisms driving melanoma ulceration are poorly understood.
  • MicroRNAs (miRs) are key regulators of gene expression implicated in cancer.

Purpose of the Study:

  • To investigate the unique microRNA (miR) expression profile in ulcerated versus nonulcerated cutaneous melanoma.
  • To identify potential inverse correlations between miR expression and their target messenger RNAs (mRNAs).

Main Methods:

  • Expression profiling of miRs and mRNAs in ulcerated and nonulcerated melanoma tissues using NanoString assays.
  • Validation in an independent patient cohort.
  • Bioinformatic analysis for pathway enrichment, functional annotation, and miR-mRNA correlation.

Main Results:

  • A distinct set of 24 miRs showed differential expression in ulcerated melanoma.
  • Significant downregulation of miR-206, miR-1-3p, and miR-4286 was observed.
  • Upregulation of miR-146a-5p, miR-196b-5p, and miR-363-3p was noted.
  • 21 differentially expressed mRNAs were identified, with two showing inverse correlation with regulatory miRs (SOCS3/miR-218-5p and IL7R/miR-376c-5p).

Conclusions:

  • The study identified a specific microRNA (miR) expression signature associated with ulcerated cutaneous melanoma.
  • These findings contribute to the molecular characterization of this aggressive tumor phenotype.
  • The identified miR-mRNA interactions may offer novel therapeutic targets for melanoma.